Transaldolase exchange and its effects on measurements of gluconeogenesis in humans

American Journal of Physiology - Endocrinology and Metabolism

Volumn 300, Issue 2, 2011, Pages

  Basu, Rita ^a   Barosa, Cristina ^b   Basu, Ananda ^a   Pattan, Vishwanath ^a   Saad, Ahmed ^a   Jones, John ^b   Rizza, Robert ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

3 3H glucose; 6,6 2H2 glucose; Deuterated water method; Endogenous glucose production; Transaldolase exchange reaction; Triosephosphate isomerase

Indexed keywords

C PEPTIDE; CARBON 13; DEUTERIUM OXIDE; FRUCTOSE 6 PHOSPHATE; GLUCAGON; GLUCOSE; GLUCURONIDE; INSULIN; PARACETAMOL; TRANSALDOLASE; TRITIUM;

ADULT; ARTICLE; CARBON SOURCE; ENZYME ACTIVITY; FEMALE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCOGENOLYSIS; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; MALE; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; URINE LEVEL;

ACETATES; ADULT; BLOOD GLUCOSE; C-PEPTIDE; CARBON RADIOISOTOPES; DEUTERIUM OXIDE; FEMALE; GLUCAGON; GLUCONEOGENESIS; GLUCOSE; GLYCERALDEHYDE 3-PHOSPHATE; HUMANS; INSULIN; ISOTOPE LABELING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; TRANSALDOLASE;

EID: 79251576452     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00403.2010     Document Type: Article

References (36)

1. Adkins A, Basu R, Persson M, Dicke B, Shah P, Vella A, Schwenk WF, Rizza R. Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in non-diabetic humans. Diabetes 52: 2213-2220, 2003.
2. Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk F, Rizza R. Type 2 diabetes impairs sphlanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes 50: 1351-1362, 2001.
3. Basu R, Basu A, Chandramouli V, Norby B, Dicke B, Shah P, Cohen O, Landau BR, Rizza RA. Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes. Diabetologia 51: 2031-2040, 2008.
4. Basu R, Chandramouli V, Dicke B, Landau B, Rizza R. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes 54: 1942-1948, 2005.
5. Basu R, Chandramouli V, Schumann W, Basu A, Landau BR, Rizza RA. Additional evidence that transaldolase exchange, isotope discrimination during the triose-isomerase reaction, or both occur in humans: effects of type 2 diabetes. Diabetes 58: 1539-1543, 2009.
6. Basu R, Di Camillo B, Toffolo G, Basu A, Shah P, Vella A, Rizza R, Cobelli C. Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab 284: E55-E69, 2003.
7. Basu R, Schwenk F, Rizza RA. Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes. Am J Physiol Endocrinol Metab 287: E55-E62, 2004.
8. Bock G, Chittilapilly E, Basu R, Toffolo G, Cobelli C, Chandramouli V, Landau BR, Rizza RA. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis. Diabetes 56: 1703-1711, 2007.
9. 2O to measure gluconeogenesis in humans. Diabetes 57: 50-55, 2008.
10. Boden G, Chen X, Stein TP. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 280: E23-E30, 2001.
11. Chandramouli V, Ekberg K, Schumann WC, Kalhan SC, Wahren J, Landau BR. Quantifying gluconeogenesis during fasting. Am J Physiol Endocrinol Metab 273: E1209-E1215, 1997.
12. Chen X, Iqbal N, Boden G. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 103: 365-372, 1999.
13. Edgerton DS, Cardin S, Emshwiller M, Neal D, Chandramouli V, Schumann WC, Landau BR, Rossetti L, Cherrington AD. Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism. Diabetes 50: 1872-1882, 2001.
14. Ekberg K, Chandramouli V, Kumaran K, Schumann WC, Wahren J, Landau BR. Gluconeogenesis and glucuronidation in liver in vivo and the heterogeneity of hepatocyte function. J Biol Chem 270: 21715-21717, 1995.
15. Fletcher SJ, Herlihy JM, Albery WJ, Knowles JR. Energetics of triosephosphate isomerase: the appearance of solvent tritium in substrate glyceraldehyde 3-phosphate and in product. Biochemistry 15: 5612-5617, 1976.
16. Gastaldelli A, Baldi S, Pettiti M, Toschi E, Camastra S, Natali A, Landau BR, Ferrannini E. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 49: 1367-1373, 2000.
17. Gastaldelli A, Toschi E, Pettiti M, Frascerra S, Quiñones-Galvan A, Sironi AM, Natali A, Ferrannini E. Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. Diabetes 50: 1807-1812, 2001.
18. 13C]glucose. Am J Physiol Endocrinol Metab 278: E140-E145, 2000.
19. Hellerstein MK, Christiansen M, Kaempfer S, Kletke C, Wu K, Reid JS, Mulligan K, Hellerstein NS, Shackleton CH. Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J Clin Invest 87: 1841-1852, 1991.
20. Hellerstein MK, Neese RA, Linfoot P, Christiansen M, Turner S, Letscher A. Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study. J Clin Invest 100: 1305-1319, 1997.
21. 13C-enrichment of human glucuronide from metabolic tracers. J Carb Chem 25: 203-217, 2006.
22. Jones JG, Fagulha A, Barosa C, Bastos M, Baptista C, Caldeira MM, Carvalheiro M. Noninasive analysis of hepatic glycogen kinetics before and after brakfast with deuterated water and acetaminophen. Diabetes 55: 2294-2300, 2006.
23. Jones JG, Garcia P, Barosa C, Delgado TC, Caldeira MM, Diogo L. Quantification of hepatic transaldolase exchange activity and its effects on tracer measurements of indirect pathway flux in humans. Magn Reson Med 59: 423-429, 2008.
24. Landau B, Bartsch GE. Estimations of pathway contributions to glucose metabolism and the transaldolase reactions. J Biol Chem 241: 741-749, 1966.
25. Landau BR, Fernandez CA, Previs SF, Ekberg K, Chandramouli V, Wahren J, Kalhan SC, Brunengraber H. A limitation in the use of mass isotopomer distributions to measure gluconeogensis in fasting humans. Am J Physiol Endocrinol Metab 269: E18-E26, 1995.
26. Landau BR, Hastings AB, Nesbett FB. Origin of glucose and glycogen carbons formed from C14-labeled pyruvate by livers of normal and diabetic rats. J Biol Chem 214: 525-535, 1955.
27. 2O for estimating rates of gluconeogenesis. Application to the fasted state. J Clin Invest 95: 172-178, 1995.
28. Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC. Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 98: 378-385, 1996.
29. Magnusson I, Schumann WC, Bartsch GE, Chandramouli V, Kumaran K, Wahren J, Landau BR. Noninvasive tracing of Krebs cycle metabolism in liver. J Biol Chem 266: 6975-6984, 1991.
30. Rieder SV, Rose IA. The mechanism of the triosephosphate isomerase reaction. J Biol Chem 234: 1007-1010, 1959.
31. Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol Endocrinol Metab 240: E630-E639, 1981.
32. Roden M, Stingl H, Chandramouli V, Schumann WC, Hofer A, Landau BR, Nowotny P, Waldhäusl W, Shulman GI. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes 49: 701-707, 2000.
33. 13C NMR. Science 254: 573-576, 1991.
34. Steele R, Wall J, DeBodo R, Altszuler N. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187: 15-24, 1956.
35. Steiner KE, Mouton SM, Bowles CR, Williams PE, Cherrington AD. The relative importance of first- and second-phase isulin secretion in countering the action of glucagon on glucose turnover in the conscious dog. Diabetes 31: 964-972, 1982.
36. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration. Diabetologia 44: 729-737, 2001.